AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $175.05
-
Support level$173.68
-
Resistance level$197.38
-
Beta0.4
-
RSI (14-day)21.8
- ABBV is one of this month's worst performers with a return of -17.3 percent, underperforming 90 percent of stocks in the S&P-100.
- Down 6.4 percent, ABBV is one of this week's biggest decliners.
- Volatility is forecast to fall over the next month.
- ABBV is below its 200-day moving average - additional caution warranted in long positions.
- With RSI < 30, ABBV is oversold. Odds slightly favor a short-term price reversal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$154.79 | $216.66 | 36.6% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$187.89 | $200.55 | $199.16 | $190.09 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week12.9%
-
In the next month18.2%
-
In the next year52.2%
Period | Value |
---|---|
Historical (5 year) | 25.3% |
Last month | 22.0% |
Current estimate | 47.4% |
Next month forecast | 32.2% |